Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes
about
Bioactive lipids in Trypanosoma cruzi infectionEndothelial transmigration by Trypanosoma cruziCurrent understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas diseaseRuthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas diseaseTrypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes.Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas diseaseCrucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infectionInterferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.Caspase-1/ASC inflammasome-mediated activation of IL-1β-ROS-NF-κB pathway for control of Trypanosoma cruzi replication and survival is dispensable in NLRP3-/- macrophages.CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury.Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain).Chagas heart disease: report on recent developments.Recent developments in the interactions between caveolin and pathogens.Alterations in glucose homeostasis in a murine model of Chagas disease.The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.Chagas' disease: an update on immune mechanisms and therapeutic strategiesCould interferon-gamma be a therapeutic target for treating heart failure?Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).The effects of nitric oxide on the immune system during Trypanosoma cruzi infection.Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy.Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction.Cardiomyocyte oxidants production may signal to T. cruzi intracellular development.Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart.Therapeutic responses to different anti-Trypanosoma cruzi drugs in experimental infection by benznidazole-resistant parasite stock.Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study.Lipid Bodies as Sites of Prostaglandin E2 Synthesis During Chagas Disease: Impact in the Parasite Escape Mechanism.Physiological and unappreciated roles of CaMKII in the heart.
P2860
Q26866224-0E02E8EA-892D-4614-9D8A-0D4163549F20Q27301348-A402D9F4-2BC7-4740-8785-F4A6241881B2Q28391025-14A47DF9-83E1-41CF-83CE-B65FE7D00B22Q28543494-E8594CE8-D1F9-4683-BFA0-1FD2AF6D78B5Q33799832-2DEE44B3-7BE8-4AEA-A584-1356D3407A1BQ33828299-3343F504-9FC7-4B49-8614-CE6ADB506FB4Q34101524-09A92B15-50E2-4159-BAB2-60F4599BBCB4Q34425347-94162336-5A8E-4B02-8F32-7F1D0AA0ADCDQ34456390-5BF3ADFA-CEDA-402E-988A-1DB694A473A6Q34880308-47A4C182-705F-472B-93F3-6F44EFBE0274Q35741974-61462C35-4F8C-440F-8D24-622C95A63896Q35745413-67FAD148-CC4E-46C4-84AF-8C2359937F60Q36586691-5A4D2383-6C78-49B7-A848-BA2C73AB23CAQ36651918-5B718DA2-477C-4F09-836B-454A12C3AED8Q36970825-31E84965-F207-4F46-88E1-2BCA6F47B733Q37310959-3C543702-D753-4F9A-937B-8F6B3DC65B37Q37351145-D5EEB76F-7E17-4734-9581-D8F835202320Q37467729-D26F626E-8A69-422D-9979-7BD98D23A86AQ37597063-9F50B109-D165-44F3-AC84-A42B24679170Q37997005-BD09B25A-AF08-4CD9-B337-AC1BEB382092Q38056907-838B2070-AC96-4659-8D5E-0A11E0E859D2Q38612615-07E216A0-0C98-4DA5-B369-41BFDA0B6C2DQ38968695-C5212ECC-92F9-4BED-8F4B-61E02EBB6889Q41308213-7125D553-0ED4-45CC-AB76-6A9B71E3FE67Q41552272-D6E26CC6-E520-455F-94EA-C14020DD57BEQ42735515-06AE45BA-B521-4039-85FE-259CAA49BAF5Q43807373-C7724448-BF80-4472-B6CA-385CE64C0F0CQ45895646-70C07284-2126-4FA9-ADC2-FD1A64932A51Q54242419-5C135A19-C444-4B6A-8932-6887F1728B68Q55381387-03965C63-CE2D-43C5-AE73-BD79AA7583AB
P2860
Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@en
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@nl
type
label
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@en
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@nl
prefLabel
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@en
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@nl
P2093
P2860
P1476
Nitric oxide synthase-2 modula ...... ruzi-infected cardiac myocytes
@en
P2093
Fabiana S Machado
Janeusa T Souto
João S Silva
Julio Aliberti
Lisia Esper
Marcos A Rossi
P2860
P304
P356
10.1016/J.MICINF.2008.09.009
P5008
P577
2008-10-08T00:00:00Z